Blockchain Registration Transaction Record
Annovis Bio Commences Phase 3 Trial for Alzheimer's Treatment
Annovis Bio (ANVS) starts Phase 3 trial for Alzheimer's treatment, secures new patent, and participates in key conferences. Cash reserves up, R&D expenses down. Learn more about the latest developments in neurodegenerative disease therapies.

This news matters as it highlights the progress made by Annovis Bio in developing innovative therapies for neurodegenerative diseases like Alzheimer's and Parkinson's. The initiation of the Phase 3 trial signifies a significant step towards potentially addressing the unmet medical needs in these conditions, offering hope for improved brain function and quality of life for patients.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x5f0b08d4e373af2ded8a94154c3790ea4cdbba23620eba2c5c9dcba8b51969d6 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | envylim9-e76affc1184c534c2ec572818a4eeec8 |